|
FOXJ2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.26139999556685E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.37689876062086E-11 |
| Normal-vs-Stage2 |
7.144000E-03 |
| Normal-vs-Stage3 |
5.022100E-03 |
| Normal-vs-Stage4 |
2.284100E-02 |
| Stage1-vs-Stage2 |
1.688620E-01 |
| Stage1-vs-Stage3 |
1.861320E-03 |
| Stage1-vs-Stage4 |
2.797900E-03 |
| Stage2-vs-Stage3 |
4.074000E-01 |
| Stage2-vs-Stage4 |
3.271600E-01 |
| Stage3-vs-Stage4 |
7.937400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.46449999904874E-08 |
| Normal-vs-AfricanAmerican |
2.025800E-02 |
| Normal-vs-Asian |
7.369900E-02 |
| Caucasian-vs-AfricanAmerican |
3.891600E-01 |
| Caucasian-vs-Asian |
2.559200E-01 |
| AfricanAmerican-vs-Asian |
2.001000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1933000005081E-07 |
| Normal-vs-Female |
1.61450000035757E-07 |
| Male-vs-Female |
4.572600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.937760E-01 |
| Normal-vs-Age(41-60Yrs) |
8.34119995296589E-10 |
| Normal-vs-Age(61-80Yrs) |
2.1791999999965E-05 |
| Normal-vs-Age(81-100Yrs) |
1.174190E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.379900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.562000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.390800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.399790E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.303600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.838000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.010000E-04 |
| Normal-vs-Grade 2 |
3.31500382699801E-11 |
| Normal-vs-Grade 3 |
9.61849999999709E-05 |
| Normal-vs-Grade 4 |
2.701400E-01 |
| Grade 1-vs-Grade 2 |
1.120210E-02 |
| Grade 1-vs-Grade 3 |
1.586010E-04 |
| Grade 1-vs-Grade 4 |
1.69037999999677E-05 |
| Grade 2-vs-Grade 3 |
2.218800E-03 |
| Grade 2-vs-Grade 4 |
5.70340000000114E-05 |
| Grade 3-vs-Grade 4 |
4.866400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.04281036531029E-14 |
| Normal-vs-ccB subtype |
6.017000E-03 |
| ccA subtype-vs-ccB subtype |
2.45570000001472E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.73269999967663E-07 |
| Normal-vs-N1 |
4.213400E-01 |
| N0-vs-N1 |
2.734600E-01 |
|
|
